Argomento della docenza: Biomarkers and treatment response or prognosis. Working towards personalized MS treatment, the epidemiology of MS: environmental factors, genetics, and their impact on disease risk and progression, Innate immunity and the pathogenesis of MS. - Ente organizzatore: Merck S.p.A
Periodo di svolgimento dell’iniziativa:
Novembre 19, 2021